ARTICLE | Clinical News
Botox onabotulinumtoxinA regulatory update
February 17, 2014 8:00 AM UTC
The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved Allergan's Botox onabotulinumtoxinA to treat ankle disability due to lower limb spasticity associated with stroke in adul...